COVID19 India

India gives Hetero Labs and Cipla approval to make Gilead’s COVID-19 drug

By Administrator_India Capital Sands   India’s drug regulator has given Hetero Labs and Cipla Ltd the green light to manufacture and market their generic version of Gilead Sciences Inc’s experimental COVID-19 treatment remdesivir, the Indian pharmaceutical companies said on Sunday. India’s Cipla said its generic version of remdesivir will be called Cipremi. The Drug Controller […]

COVID19 Economy

Global Markets: Stocks stutter as second wave virus fears test recovery hopes

By Administrator_India Capital Sands   Asian shares and U.S. stock futures wobbled in choppy trade on Friday as lingering concerns about an fresh spike in coronavirus cases offset growing hopes for a quick economic recovery. MSCI’s broadest index of Asia-Pacific shares outside Japan eased 0.06%. U.S. S&P 500 e-minis moved in and out of the […]

China India

India, China hold talks to defuse border standoff, thin out some forces

By Administrator_India Capital Sands Indian and Chinese military commanders made progress in talks on Wednesday to defuse a standoff along their disputed border in the western Himalayas after pulling back some troops in confidence-building gestures, Indian government officials said. Hundreds of soldiers have been ranged against each other in the remote snow desert of Ladakh […]